Gilead Sciences (GILD) EBIT (2009 - 2026)
Gilead Sciences posted quarterly EBIT of $2.6 billion for Q1 2026, up 15.6% year-on-year from $2.2 billion in Q1 2025, and up 30.34% on a QoQ basis from $2.0 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of EBIT data on file, last reported at $2.6 billion in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 15.6% year-over-year to $2.6 billion; the trailing twelve-month figure through Mar 2026 stood at $10.4 billion (up 26.15% YoY), and the FY2025 full-year result was $10.0 billion, up 503.01% from the prior year.
- EBIT for Q1 2026 stood at $2.6 billion, up from $2.0 billion in the prior quarter.
- Across five years, EBIT topped out at $3.3 billion in Q3 2025 and bottomed at -$4.3 billion in Q1 2024.
- The 5-year median for EBIT is $2.2 billion (2025), against an average of $1.7 billion.
- The widest annual swing landed in 2023, when EBIT soared 765.48%; it then slumped 353.49% in 2024.
- A 5-year view of EBIT shows it stood at $2.3 billion in 2022, then dropped by 28.89% to $1.6 billion in 2023, then jumped by 52.11% to $2.5 billion in 2024, then retreated by 19.09% to $2.0 billion in 2025, then surged by 30.34% to $2.6 billion in 2026.
- The last three EBIT figures came in at $2.6 billion (Q1 2026), $2.0 billion (Q4 2025), and $3.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 9.50 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 6.36 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 3.99 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -7.73 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 2.67 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 2.59 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -6.71 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -182.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.59 Bn |
| Dec 31, 2025 | 1.98 Bn |
| Sep 30, 2025 | 3.33 Bn |
| Jun 30, 2025 | 2.47 Bn |
| Mar 31, 2025 | 2.24 Bn |
| Dec 31, 2024 | 2.45 Bn |
| Sep 30, 2024 | 888.00 Mn |
| Jun 30, 2024 | 2.64 Bn |
| Mar 31, 2024 | -4.32 Bn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 1.67 Bn |
| Mar 31, 2023 | 1.71 Bn |
| Dec 31, 2022 | 2.27 Bn |
| Sep 30, 2022 | 2.84 Bn |
| Jun 30, 2022 | 2.03 Bn |
| Mar 31, 2022 | 197.00 Mn |
| Dec 31, 2021 | 940.00 Mn |
| Sep 30, 2021 | 3.84 Bn |
| Jun 30, 2021 | 2.25 Bn |
| Mar 31, 2021 | 2.89 Bn |
| Dec 31, 2020 | 2.65 Bn |
| Sep 30, 2020 | 2.00 Bn |
| Jun 30, 2020 | -2.98 Bn |
| Mar 31, 2020 | 2.40 Bn |
| Dec 31, 2019 | 1.09 Bn |
| Sep 30, 2019 | -1.47 Bn |
| Jun 30, 2019 | 2.43 Bn |
| Mar 31, 2019 | 2.24 Bn |
| Dec 31, 2018 | 1.14 Bn |
| Sep 30, 2018 | 2.62 Bn |
| Jun 30, 2018 | 2.28 Bn |
| Mar 31, 2018 | 2.15 Bn |
| Dec 31, 2017 | 675.00 Mn |
| Sep 30, 2017 | 3.81 Bn |
| Jun 30, 2017 | 4.25 Bn |
| Mar 31, 2017 | 3.77 Bn |
| Dec 31, 2016 | 4.05 Bn |
| Sep 30, 2016 | 4.40 Bn |
| Jun 30, 2016 | 4.54 Bn |
| Mar 31, 2016 | 4.65 Bn |
| Dec 31, 2015 | 5.62 Bn |
| Sep 30, 2015 | 5.59 Bn |
| Jun 30, 2015 | 5.62 Bn |
| Mar 31, 2015 | 5.37 Bn |
| Dec 31, 2014 | 4.33 Bn |
| Sep 30, 2014 | 3.48 Bn |
| Jun 30, 2014 | 4.41 Bn |
| Mar 31, 2014 | 3.04 Bn |
| Dec 31, 2013 | 1.20 Bn |
| Sep 30, 2013 | 1.15 Bn |
| Jun 30, 2013 | 1.15 Bn |
| Mar 31, 2013 | 1.03 Bn |
| Dec 31, 2012 | 1.11 Bn |
| Sep 30, 2012 | 1.04 Bn |
| Jun 30, 2012 | 1.06 Bn |
| Mar 31, 2012 | 800.19 Mn |
| Dec 31, 2011 | 867.48 Mn |
| Sep 30, 2011 | 1.00 Bn |
| Jun 30, 2011 | 1.02 Bn |
| Mar 31, 2011 | 901.97 Mn |
| Dec 31, 2010 | 829.38 Mn |
| Sep 30, 2010 | 979.07 Mn |
| Jun 30, 2010 | 992.63 Mn |
| Mar 31, 2010 | 1.16 Bn |
| Dec 31, 2009 | 1.07 Bn |
| Sep 30, 2009 | 894.41 Mn |
| Jun 30, 2009 | 761.06 Mn |
| Mar 31, 2009 | 808.32 Mn |